🧬 PANCRAGEN: WHAT IS IT?
Pancragen shows up on a lot of bioregulator lists. Here's what it is in plain English.
WHAT IT IS
• A short lab-made peptide (4 amino acids) from the Khavinson bioregulator family
• Linked to pancreas tissue — the organ that makes insulin and digestive enzymes
• Sequence often written as Lys-Glu-Asp-Trp (KEDW)
WHAT PEOPLE LOOK AT IT FOR
• Healthy-aging interest around pancreas and metabolic support
• Research talk about pancreas tissue and gene activity
• Not the same as insulin, metformin, or any approved diabetes medicine
WHAT THE RESEARCH ACTUALLY SHOWS
• Cell and tissue studies on pancreas-related gene activity
• Rodent work on aging and pancreas tissue
• Almost all of it comes from one research group in Russia
• No large independent human trials that prove a clinical benefit
Evidence level: Early (cell/animal; single research lineage).
GOOD TO KNOW
• Not FDA approved for any use
• Not a blood-sugar treatment and not a substitute for prescribed care
• "Pancreas" on the label does not mean it rebuilds or fixes that organ in people
HOW TO READ A COA (IF YOU SEE ONE)
• Name and lot number match the vial
• Mass spec matches the expected peptide weight
• HPLC purity with a recent test date
• A third-party lab you can look up yourself
For research use only, not medical advice.
Takeaway: Pancragen is an early-stage pancreas-linked bioregulator idea from one research line, not a proven pancreas fix.